JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
The strictly regulated unidirectional differentiation program in some somatic stem/progenitor cells has been found to be modified in the ectopic site (tissue) undergoing regeneration. In these cases, the lineage barrier is crossed by either heterotypic cell fusion or direct differentiation. Though s...
Main Authors: | Veena Kochat, Zaffar Equbal, Prakash Baligar, Vikash Kumar, Madhulika Srivastava, Asok Mukhopadhyay |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5362104?pdf=render |
Similar Items
-
A Two-Stage Process for Differentiation of Wharton’s Jelly-Derived Mesenchymal Stem Cells into Neuronal-like Cells
by: Zaffar Equbal, et al.
Published: (2021-01-01) -
Epigenetic Reprogramming of Muscle Progenitors: Inspiration for Clinical Therapies
by: Silvia Consalvi, et al.
Published: (2016-01-01) -
JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency
by: Yinghua Huang, et al.
Published: (2020-10-01) -
JMJD3: a critical epigenetic regulator in stem cell fate
by: Yuanjie Ding, et al.
Published: (2021-07-01) -
Innate Immune Cell Phenotypes Are Dictated by Distinct Epigenetic Reprogramming
by: Adams, Kevin Douglas
Published: (2018)